Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportMolecular Targeting Probes-Radioactive & Nonradioactive - Dosimetry & Image Analysis

90Y SIR-Spheres Activity Measurement with the New SIROS D-Vial Delivery Kit

Benjamin Lopez, E Courtney Henry, Adam Riggs and S. Cheenu Kappadath
Journal of Nuclear Medicine June 2023, 64 (supplement 1) P164;
Benjamin Lopez
1UT MD Anderson Cancer Center
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
E Courtney Henry
1UT MD Anderson Cancer Center
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adam Riggs
2Sirtex Medical Ltd.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S. Cheenu Kappadath
1UT MD Anderson Cancer Center
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Abstract

P164

Introduction: Successful treatment delivery and accurate dosimetry in 90Y-microsphere radioembolization of liver tumors requires accurate pre- and post-treatment 90Y activity assays. Currently at our institution, SIR-Spheres doses in traditional V-Vials for patient administration are verified with dose calibrators: Capintec CRC-15R (calibration number, Cal. #, 63x10) or CRC-55tR (Cal. # 65x10). As additional verification, the exposure rate (with Fluke 451B ionization chamber) from the V-Vial in acrylic shield at 30 cm is converted to activity using a calibration factor of 0.0606 mR/hr/mCi. Sirtex has introduced a new SIR-Spheres delivery kit that includes a SIROS D-Vial and acrylic shield – both with different form factors and geometries from the traditional V-Vial setup. The purpose of this work is to establish the appropriate CRC-15R and CRC-55tR calibration numbers and exposure rate conversion factor to accurately assay 90Y activity in the new SIROS D-Vial and acrylic shield form factor.

Methods: Five D-Vials were prepared according to manufacturer instructions with initial 90Y-microspheres activities of 32.1, 34.1, 58.1, 78.9, and 171.3 mCi. Agitated D-Vials within their acrylic shields were each assayed in triplicate over several days in 2 separate CRC-55tR and 2 separate CRC-15R dose calibrators using Cal. #s ranging from 54-65x10 until activity levels reached approximately 10 mCi. Likewise, exposure rates of the agitated D-Vials within their acrylic shields were measured multiple times over this time using 2 separate Fluke 451B meters. Given the asymmetrical form factor of the D-Vial and acrylic shield, exposure rates at 30 cm were measured with the D-Vials tubing facing away, toward, and orthogonal the ion chamber. The best Cal. # for each dose calibrator model was identified as the value resulting in the lowest median relative error across all vials. The exposure rate calibration factor was calculated as the best-fit slope of a line (y-intercept = 0) in a plot of exposure rate (mR/hr) versus known activity (mCi).

Results: The lowest 90Y activity measurement errors in agitated D-Vials were achieved on CRC-15R dose calibrators using Cal. # 60x10 (-0.2% median, -1.2% to 1.0% interquartile range IQR, -3.9% to 2.4% range) and on CRC-55tR dose calibrators using Cal. # 59x10 (0.3% median, -0.4% to 1.5% IQR, -1.9% to 4.1% range). The errors were relatively constant between activities 40-160 mCi but did increase by ~2% as activity decayed below 20 mCi. For comparison, using the V-Vial Cal. #s resulted in errors of -1.7% median (-2.9% to -1.5% IQR) with CRC-15R and errors of -3.8% median (-4.8% to -1.5% IQR) with CRC-55tR. In 4 of the 5 D-Vials, the measured exposure rates were relatively consistent regardless of the positioning of the D-Vial tubing relative to the ion chamber. In the 5th D-Vial, some measurements at activities above 80 mCi differed by up to 50% with both Fluke 541b meters. Therefore, only the 4 D-Vial data were used to determine the exposure rate conversion factor, as we investigate the source of the discrepancy in the 5th D-Vial (e.g., specifications for thickness consistency in acrylic shield manufacturing). The resulting best-fit slope was 0.0546 mR/hr/mCi, 10% lower than the V-Vial exposure rate conversion factor.

Conclusions: For accurate SIR-Spheres assays in the new SIROS D-Vial delivery set, 90Y-microsphere activities in agitated D-Vials should be measured in dose calibrators with calibration numbers 60x10 for CRC-15R and 59x10 for CRC-55tR. If assaying the activity indirectly through an exposure rate measurement, a conversion factor of 0.0546 mR/hr/mCi should be used when measuring with Fluke 451B ionization chambers at 30 cm. Incorrectly implemented V-Vial calibration numbers or exposure rate conversion factors will introduce errors ranging from 2-10%.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 64, Issue supplement 1
June 1, 2023
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
90Y SIR-Spheres Activity Measurement with the New SIROS D-Vial Delivery Kit
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
90Y SIR-Spheres Activity Measurement with the New SIROS D-Vial Delivery Kit
Benjamin Lopez, E Courtney Henry, Adam Riggs, S. Cheenu Kappadath
Journal of Nuclear Medicine Jun 2023, 64 (supplement 1) P164;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
90Y SIR-Spheres Activity Measurement with the New SIROS D-Vial Delivery Kit
Benjamin Lopez, E Courtney Henry, Adam Riggs, S. Cheenu Kappadath
Journal of Nuclear Medicine Jun 2023, 64 (supplement 1) P164;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Impact of Segmentation Methods on Healthy Organ and Tumor Activity Estimates for 177Lu-DOTATATE Therapy – Results from SNMMI 177Lu Dosimetry Challenge
  • [134Ce]Ce-RPS-088 as a PET Imaging Surrogate for [225Ac]Ac-RPS-088 in a Model of Prostate Cancer: Early Preclinical Evaluation
  • Radiation Dosimetry Estimates for LM Treatment using Intraventricular Injection of I-131, F-18, Cu64, Ga-67, Lu-177, Re-186 and Sn-117m radiopharmaceuticals
Show more Molecular Targeting Probes-Radioactive & Nonradioactive - Dosimetry & Image Analysis

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire